Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

A 30-second breath test that could detect pancreatic cancer is being trialled in Wrexham. Pancreatic cancer is the deadliest common cancer, with half of people dying within just three months of their diagnosis. About 530 people are diagnosed with the disease annually in Wales.

Popular NAD+-boosting supplements like NMN and nicotinamide riboside may shield pancreatic cancer cells from chemotherapy, a new study warns.

Sabina McMahon was diagnosed with osteosarcoma, a form of bone cancer, when she was 12 years old. After chemotherapy, radiation and surgery to remove the affected leg bone, she was cancer-free for more than a year,

The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a new avenue of treatment, but the available evidence is still limited.

Scientists said the drug trial of the treatment for melanoma could be the beginning of a transformation in care.

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of treatment that doctors hope will work against many types of tumors.

Cancer is the top condition driving healthcare spending for the fifth year in a row, a new report from the Business Group on Health shows.